? Cancer Prevention and Control Program The UNC Lineberger Cancer Prevention and Control Program focuses on the development, evaluation, and dissemination of evidence-based interventions and policy approaches to improve cancer outcomes in North Carolina and beyond. Our program is comprised of leading scientists and clinicians with backgrounds in psychology, sociology, health behavior, health services research, nutrition, exercise physiology, statistics, nursing and oncology all focused on improving understanding of the prevention and control of cancer. There are four broad themes in the program: (1) implementing health promotion interventions to reduce cancer risk factors and eliminate cancer health disparities; (2) developing cancer communication strategies to improve cancer outcomes; (3) improving quality of cancer care and long-term outcomes for cancer survivors; and (4) studying patterns of cancer care, screening, and prevention to inform interventions and policy initiatives that improve cancer outcomes. The program has received substantial new investment in infrastructure, research support and recruitment as befits one of three major UNC Lineberger strategic directions, ?Optimizing Cancer Outcomes in North Carolina?. Highlights of nationally recognized research by program investigators include tobacco control policy research that guides state and national policy on the sales and marketing of electronic cigarettes, and design of graphic cigarette warning labels; research on Internet and mobile interventions for diet/obesity/physical activity in adolescents and adults with a particular focus on disadvantaged populations and cancer survivors; understanding the impact of message tailoring and other health communication strategies; development of national cancer survivorship care plans; creation of unique multi-payer linked databases for cancer outcomes research; and novel patient-reported outcomes studies that inform national policy. The Program is led by Dr. Kurt Ribisl, a behavioral scientist and Dr. Ethan Basch, a medical oncologist and health services researcher. Program members are PIs of three NCI funded pre- and post-doctoral training grants. The Program adds value in terms of integrative activities and opportunities for collaboration, access to shared resources, such as the Communications for Health Applications and Interventions, Biostatistics, and Outcomes Cores, as well as space, seminars, retreats, and training and education. UNC Lineberger has benefited the Program through strong support for faculty recruitments, extensive use of shared resources, and providing developmental funds. Significant faculty recruiting supported by the Center has resulted in 22 new program members including nationally-recognized senior investigators and promising junior faculty. There are 45 program members and our program has strong collaborations between faculty from the Schools of Medicine, Public Health, Nursing, and Journalism and the College of Arts and Sciences. During the last funding period, program members have published 951 cancer-related articles (34% collaborative). In 2014, our program members held 93 grants and $31M (total cost) in annual extramural funding, including 38 grants and $13.6M (total costs) from the NCI. Program members accrued 1984 subjects to research studies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-44
Application #
9834879
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-12-01
Budget End
2020-11-30
Support Year
44
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Song, Wantong; Shen, Limei; Wang, Ying et al. (2018) Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap. Nat Commun 9:2237
Kaur, Gurpreet; Guruprasad, Kunchur; Temple, Brenda R S et al. (2018) Structural complexity and functional diversity of plant NADPH oxidases. Amino Acids 50:79-94
McNeill, Robert S; Stroobant, Emily E; Smithberger, Erin et al. (2018) PIK3CA missense mutations promote glioblastoma pathogenesis, but do not enhance targeted PI3K inhibition. PLoS One 13:e0200014
Graham-Gurysh, Elizabeth; Moore, Kathryn M; Satterlee, Andrew B et al. (2018) Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection. Mol Pharm 15:1309-1318
Trout, Susan; Goldstein, Adam O; Marks, Lawrence et al. (2018) Treating Tobacco Use in Patients with Incurable Malignancies: Should We Even Start the Conversation? J Palliat Med 21:746-750
Lee, Clara Nan-Hi; Pignone, Michael Patrick; Deal, Allison M et al. (2018) Accuracy of Predictions of Patients With Breast Cancer of Future Well-being After Immediate Breast Reconstruction. JAMA Surg 153:e176112
Ricketts, Christopher J; De Cubas, Aguirre A; Fan, Huihui et al. (2018) The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep 23:313-326.e5
Golden, Shelley D; Kong, Amanda Y; Lee, Joseph G L et al. (2018) Disparities in cigarette tax exposure by race, ethnicity, poverty status and sexual orientation, 2006-2014, USA. Prev Med 108:137-144
Morgan, Jennifer C; Southwell, Brian G; Noar, Seth M et al. (2018) Frequency and Content of Conversations About Pictorial Warnings on Cigarette Packs. Nicotine Tob Res 20:882-887
Liu, Qi; Zhu, Hongda; Liu, Yun et al. (2018) BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma. Cancer Immunol Immunother 67:299-310

Showing the most recent 10 out of 1525 publications